We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Ingenuity Expands Scope of Licensing Agreement with Daiichi
News

Ingenuity Expands Scope of Licensing Agreement with Daiichi

Ingenuity Expands Scope of Licensing Agreement with Daiichi
News

Ingenuity Expands Scope of Licensing Agreement with Daiichi

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Ingenuity Expands Scope of Licensing Agreement with Daiichi"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Ingenuity Systems has announced that they have expanded the terms of their existing agreement with Daiichi Pharmaceutical Co., Ltd. for access to the Ingenuity Pathways Analysis software.

Ingenuity Pathways Analysis (IPA) is a software application that is designed to enable researchers to model, analyze and understand the complex biological systems at the core of life science research.

IPA is deployed in most major pharmaceutical companies and hundreds of biotechnology companies and academic institutions globally.

It supports analysis of all high throughput analysis platforms and is used in virtually all areas of drug discovery and development from target identification and validation to biomarkers, predictive toxicology, and pharmacogenomics.

"Daiichi is one of the first Japanese Pharmaceutical companies to fully expand usage to a corporate wide license and we are very pleased that Daiichi has decided to broadly deploy IPA across its discovery and development sites," stated Peter DiLaura, Vice President, Sales and Customer Support.

"The Ingenuity product line enables IPA users to understand complex biology within their research, in addition to supporting the Bioinformatics team to further develop robust and proprietary computational solutions."

Ingenuity Pathways Analysis is available as a web-delivered, hosted, or deployed solution. Fully functional complimentary trials are available online.

Advertisement